Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer

[1]  P. Hall,et al.  Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients , 2020, Cancer Causes & Control.

[2]  P. Hall,et al.  Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden , 2020, Breast.

[3]  Hyeon Jun Jang,et al.  Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement , 2020, European Radiology.

[4]  S. Zackrisson,et al.  Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer , 2019, BMC Cancer.

[5]  E. Winer,et al.  Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  L. Eriksson,et al.  Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer , 2018, JNCI cancer spectrum.

[7]  S. Vinnicombe,et al.  Breast density: why all the fuss? , 2017, Clinical radiology.

[8]  K. Czene,et al.  Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach , 2017, American journal of epidemiology.

[9]  Z. Horváth,et al.  Recent Advances in the Neoadjuvant Treatment of Breast Cancer , 2017, Journal of breast cancer.

[10]  Karla Kerlikowske,et al.  Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening. , 2016, Radiology.

[11]  M. Miyazaki,et al.  Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients , 2015, Cancer medicine.

[12]  G. Gulsen,et al.  Imaging Breast Density: Established and Emerging Modalities1 , 2015, Translational oncology.

[13]  Gretchen L. Gierach,et al.  Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. , 2015, Journal of the National Cancer Institute.

[14]  A. Schneeweiss,et al.  Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials , 2015, Breast Cancer Research and Treatment.

[15]  S. Fox,et al.  International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013). , 2011, Journal of the National Cancer Institute. Monographs.

[16]  M. McEntee,et al.  Measurement of breast density with digital breast tomosynthesis--a systematic review. , 2014, The British journal of radiology.

[17]  Woo Kyung Moon,et al.  Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer , 2012, Breast Cancer Research.

[18]  A. Tutt,et al.  Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer , 2012, Annals of Surgical Oncology.

[19]  Andrew R. Green,et al.  MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups , 2011, Breast Cancer Research and Treatment.

[20]  R. Warren,et al.  Initial experiences of using an automated volumetric measure of breast density: the standard mammogram form. , 2006, The British journal of radiology.

[21]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[22]  N. Kapucuoglu,et al.  The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer , 1996, Histopathology.